BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹33 Cr | ₹40 Cr | ₹41 Cr | ₹29 Cr | ₹25 Cr |
What is the latest Net Current Assets ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹29 Cr |
| Mar2021 | ₹25 Cr |
How is Net Current Assets of BAFNA PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | -17.16 | |
| Mar2024 | ₹40 Cr | -2.81 | |
| Mar2023 | ₹41 Cr | 41.46 | |
| Mar2022 | ₹29 Cr | 13.83 | |
| Mar2021 | ₹25 Cr | - | |
Compare Net Current Assets of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹585.4 Cr | -4% | 1.9% | 170.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -4% |
1.9% |
170.2% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses